...
首页> 外文期刊>Journal of Pharmaceutical and Biomedical Analysis: An International Journal on All Drug-Related Topics in Pharmaceutical, Biomedical and Clinical Analysis >Evaluation of a novel diffusion cell for in vitro transdermal permeation: effects of injection height, volume and temperature.
【24h】

Evaluation of a novel diffusion cell for in vitro transdermal permeation: effects of injection height, volume and temperature.

机译:用于体外透皮渗透的新型扩散池的评估:注射高度,体积和温度的影响。

获取原文
获取原文并翻译 | 示例
           

摘要

The objective of this study was to evaluate the performance of a new, compact, dynamic diffusion cell for in vitro transdermal permeation. These so-called Kelder-cells were developed as an automated alternative to the static Franz diffusion cells. The new cells were used in combination with the ASPEC-system (automatic sample preparation with extraction columns) which was initially designed for the automation of solid-phase extractions. Three variables were tested to optimize the performance of the new cell system: injection height into the inlet compartment, volume flowing through the receptor compartment and temperature. Experiments were performed using the tritium labelled anticholinergic [3H]dexetimide permeating through an artificial membrane (Silastic). The injection height of the needle into the inlet compartment of the cell should be programmed at -34 mm to ensure complete air tightness, thus forcing the buffer to flow through the cell. The volume of buffer flow through the receptor compartment is important in maintaining sink conditions: a volume of 117 microliters was chosen to replace the total content of the cell (84 microliters) every 2 min. The temperature was precisely controlled in a thermostatic cabinet to minimize variations in experimental conditions. For [3H]dexetimide, an increase in temperature of 20 degrees C reduced the lag time by a factor of approximately two, however the influence on the flux was negligible. The data for the Kelder-cells were comparable with static Franz diffusion cells at a pseudo-steady state, however Kelder-cells have the advantage of automatic sampling, continuous replacement of the receptor solution, and unattended operation over at least 24 h.
机译:本研究的目的是评估新型,紧凑,动态扩散池在体外透皮渗透中的性能。这些所谓的Kelder电池是作为静态Franz扩散电池的自动化替代品而开发的。新的样品池与ASPEC系统(带萃取柱的自动样品制备)结合使用,该系统最初设计用于固相萃取的自动化。测试了三个变量以优化新电池系统的性能:进样室的注入高度,通过受体室的流量和温度。使用using标记的抗胆碱能[3H] dexetimide透过人工膜(Silastic)进行实验。针头进入细胞入口隔室的注射高度应设置为-34 mm,以确保完全的气密性,从而迫使缓冲液流过细胞。通过受体隔室的缓冲液流量对于维持水槽条件很重要:每2分钟选择117微升的体积来代替细胞的总含量(84微升)。在恒温柜中精确控制温度,以最大程度减少实验条件的变化。对于[3H]地西tim丙啶,温度升高20℃可使滞后时间减少了大约两倍,但是对通量的影响可以忽略不计。 Kelder细胞的数据与伪稳态下的静态Franz扩散细胞相当,但是Kelder细胞具有自动采样,连续替换受体溶液以及在至少24小时内无人值守操作的优势。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号